Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review.

ABSTRACT:

Background

Hepatocellular carcinoma (HCC) accounts for more than 85%-90% of primary liver cancer globally, and approximately 45% of deaths from HCC occur in greater China. This disease poses a significant economic burden for patients, payers and society and significantly affects patients' quality of life (QoL). However, such impact of HCC in greater China has not been well characterized. This review was conducted to analyze the current evidence about the economic and humanistic impact of HCC in greater China for informing national disease management and identifying clinical gaps yet to be resolved.

Methods

A systematic search literature using seven databases (Web of Science, PubMed, Medline, Cochrane Central, China National Knowledge Infrastructure, Wanfang, and Weipu) was p

SUBMITTER: Zou H 

PROVIDER: S-EPMC9068962 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature